You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
力生製藥(002393.SZ):參股公司天士力集團正在籌劃其控股子公司天士力的股份轉讓事宜

格隆匯8月2日丨力生製藥(002393.SZ)公佈,日前,公司子公司天津市中央藥業有限公司(以下簡稱"中央藥業")收到其參股公司天士力生物醫藥產業集團有限公司(以下簡稱"天士力集團")通知,稱其正在籌劃關於其控股子公司天士力醫藥集團股份有限公司(證券代碼:600535,證券簡稱:天士力)的股份轉讓事宜,該事項可能導致天士力醫藥集團股份有限公司的控制權發生變更。

公司子公司中央藥業持有天士力集團12.15%股權,為中央藥業參股公司,作為以公允價值計量且其變動計入其他綜合收益的非交易性權益工具投資核算。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account